Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID?19 pandemic in China: a qualitative study

Introduction The COVID-19 pandemic has affected antiretroviral therapy (ART) continuity among people living with HIV (PLHIV) worldwide. We conducted a qualitative study to explore barriers ART maintenance and solutions interruption when stringent control measures were implemented in China, from the perspective of PLHIV relevant key stakeholders. Methods Between 11 February 15 2020, we interviewed PLHIV, community-based organization (CBO) workers, staff centres for disease prevention (CDC) at various levels whose work is care (CDC staff), doctors nurses drug vendors regions China. Semi-structured interviews using messaging social media app. Challenges responses during discussed. Themes identified by transcript coding mindmaps. Results Sixty-four stakeholders recruited, including 16 17 CBO CDC staff, 14 two vendors. Many responsible delivery shifted response efforts. Barriers (a) travel restrictions, (b) inadequate communication bureaucratic obstacles, (c) shortage personnel, (d) privacy concerns, (e) insufficient reserve. helped maintain access through five thematic analysis: coordination refill local clinics or hospitals, mail, protection measures, mental health counselling, providing connections alternative sources ART. Drug contributed selling out-of-pocket Conclusions Social institutional disruption increased risk Collaboration was needed ART, playing an important role. Other countries facing current future public emergencies may learn employed